Evidence mapPaperPMID 42573675Full record

ArticleJournal of endocrinological investigation2026

Dynamic patterns of thyroid hormones and incident chronic kidney disease: evidence from 18 years of follow-up in the Tehran Thyroid Study.

Atieh Amouzegar, Sadaf Agahi, Safdar Masoumi, Mohamadamin Tarighat-Payma, Mohammadjavad Honarvar, Fereidoun Azizi, Ladan Mehran

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of endocrinological investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Atieh AmouzegarEndocrine Research Center, Research Institute for Endocrine Disorders, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0001-9433-9408
Sadaf AgahiEndocrine Research Center, Research Institute for Endocrine Disorders, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0009-0004-1446-2051
Safdar MasoumiEndocrine Research Center, Research Institute for Endocrine Disorders, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0003-1520-9344
Mohamadamin Tarighat-PaymaEndocrine Research Center, Research Institute for Endocrine Disorders, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0009-0002-0900-7770
Mohammadjavad HonarvarEndocrine Research Center, Research Institute for Endocrine Disorders, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0002-3650-4951
Fereidoun AziziEndocrine Research Center, Research Institute for Endocrine Disorders, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0002-6470-2517
Ladan MehranEndocrine Research Center, Research Institute for Endocrine Disorders, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. lmehran@endocrine.ac.ir.ORCID http://orcid.org/0000-0001-8568-7419

Funding

Shahid Beheshti University of Medical Sciences 43007178-4
6 · The paper itself

Abstract

backgroundThis population-based cohort study aimed to determine if longitudinal patterns of thyroid-stimulating hormone (TSH) and free thyroxine (FT4) are associated with the risk of developing chronic kidney disease (CKD) over 18 years.

methodsIn this prospective cohort study, 3,851 adults aged ≥ 20 years from the Tehran Thyroid Study (TTS) who remained free of CKD during the thyroid trajectory assessment period (visits 1-3, approximately 9 years) were included. Serum TSH and FT4 were measured at three visits, and latent growth mixture modeling (LGMM) was used to identify distinct hormone trajectories. Incident CKD, defined as an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m², was prospectively ascertained during a subsequent outcome assessment period spanning visits 4-6 (approximately 9 years). Cox proportional hazards models were used to evaluate the association between thyroid hormone trajectories and CKD risk after adjustment for potential confounders.

resultsTSH trajectory patterns were characterized as high-increasing, mild-increasing, mild-decreasing, and moderate-decreasing, with 39% of participants experiencing a rising trend in TSH levels over time. Adults displaying a high-increasing TSH trajectory faced a significantly elevated risk of CKD (HR: 1.34; 95% CI: 1.06-1.70) compared to those with a mild-decreasing TSH trajectory, independent of baseline kidney function and other confounders. While a mild-increasing TSH trajectory was initially associated with a higher risk of CKD, the association did not persist after adjustment for initial eGFR. FT4 trajectories predominantly exhibited a decreasing trend, with four identified patterns ranging from stable to high decreasing levels, and showed no significant or consistent relationship with CKD incidence after full adjustment.

conclusionA high-increasing TSH trajectory was associated with a higher subsequent hazard of incident CKD, whereas FT4 trajectories showed no consistent independent association. These findings should be interpreted cautiously and may reflect broader physiological dysregulation rather than a direct thyroid hormone-mediated renal mechanism.

Indexed as

Chronic kidney diseaseCohort studiesThyroid hormonesTrajectory

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.